Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2024, Ercros has already paid €0.096 in dividends. The last payout was in July 2024.

Financials

In the last quarter, Ercros had revenue of €214.4m and net profit of €9.71m
(EUR) June 2026
YoY
Revenue 214.4m 27.98%
Gross profit 89.31m 59.60%
Net profit 9.71m 156.73%
EBITDA 19.88m 191.26%

Fundamentals

Metric Value
Market capitalization
€319.11m
Number of shares
91.44m
52-week high/low
€3.50 - €2.23
Dividends No
Beta
0.19
P/E ratio
-7.93
PEG ratio
0.25
P/B ratio
1.13
P/S ratio
0.40

Company profile

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry. The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Name
Ercros
CEO
Joao Maria Guimaraes Jose de Mello
Headquarters Barcelona,
Spain
Website
Sector
Materials
Industry
Chemicals
IPO
03/01/2000
Employees 1,346

Ticker symbols

Exchange Symbol
Bme
ECR.MC
Frankfurt
CRS1.F
Düsseldorf
CRS1.DU
Madrid
ECR.MC
London
0M0E.L
München
CRS1.MU
🍪

Parqet  uses cookies. Learn more